SARS Molecular Detection External Quality Assurance

Inactivated severe acute respiratory syndrome–associated coronavirus samples were used for an external quality assurance study within the World Health Organization SARS Reference and Verification Network and other reference institutions. Of 58 participants, 51 correctly detected virus in all samples...

Descripción completa

Detalles Bibliográficos
Autores principales: Drosten, Christian, Doerr, Hans Wilhelm, Lim, Wilina, Stöhr, Klaus, Niedrig, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2004
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323363/
https://www.ncbi.nlm.nih.gov/pubmed/15663861
http://dx.doi.org/10.3201/eid1012.040416
_version_ 1782229182882775040
author Drosten, Christian
Doerr, Hans Wilhelm
Lim, Wilina
Stöhr, Klaus
Niedrig, Matthias
author_facet Drosten, Christian
Doerr, Hans Wilhelm
Lim, Wilina
Stöhr, Klaus
Niedrig, Matthias
author_sort Drosten, Christian
collection PubMed
description Inactivated severe acute respiratory syndrome–associated coronavirus samples were used for an external quality assurance study within the World Health Organization SARS Reference and Verification Network and other reference institutions. Of 58 participants, 51 correctly detected virus in all samples >9,400 RNA copies per milliliter and none in negative samples. Commercial test kits significantly improved the outcome.
format Online
Article
Text
id pubmed-3323363
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-33233632012-04-18 SARS Molecular Detection External Quality Assurance Drosten, Christian Doerr, Hans Wilhelm Lim, Wilina Stöhr, Klaus Niedrig, Matthias Emerg Infect Dis Dispatch Inactivated severe acute respiratory syndrome–associated coronavirus samples were used for an external quality assurance study within the World Health Organization SARS Reference and Verification Network and other reference institutions. Of 58 participants, 51 correctly detected virus in all samples >9,400 RNA copies per milliliter and none in negative samples. Commercial test kits significantly improved the outcome. Centers for Disease Control and Prevention 2004-12 /pmc/articles/PMC3323363/ /pubmed/15663861 http://dx.doi.org/10.3201/eid1012.040416 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Drosten, Christian
Doerr, Hans Wilhelm
Lim, Wilina
Stöhr, Klaus
Niedrig, Matthias
SARS Molecular Detection External Quality Assurance
title SARS Molecular Detection External Quality Assurance
title_full SARS Molecular Detection External Quality Assurance
title_fullStr SARS Molecular Detection External Quality Assurance
title_full_unstemmed SARS Molecular Detection External Quality Assurance
title_short SARS Molecular Detection External Quality Assurance
title_sort sars molecular detection external quality assurance
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323363/
https://www.ncbi.nlm.nih.gov/pubmed/15663861
http://dx.doi.org/10.3201/eid1012.040416
work_keys_str_mv AT drostenchristian sarsmoleculardetectionexternalqualityassurance
AT doerrhanswilhelm sarsmoleculardetectionexternalqualityassurance
AT limwilina sarsmoleculardetectionexternalqualityassurance
AT stohrklaus sarsmoleculardetectionexternalqualityassurance
AT niedrigmatthias sarsmoleculardetectionexternalqualityassurance

Ejemplares similares